Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lab Corp. Amer. (LH) nyse, at $ 2 1/2, exhaustion low ? -- Ignore unavailable to you. Want to Upgrade?

To: gbucks who wrote (50)	2/25/2000 9:34:00 AM
From: hoyasaxa	Respond to of 62

Disagree on all counts. Continued strong pricing and volume trends in the industry, continued shift toward higher margin product mix (lh is the stealth genomics company via its genotyping leadership) and a strong magament team -- in conjunction with the fact that they will most likely take out the pfd shares early summer (lifting the overhang from the common), leads me to continue to believe a $4.5 to $5.5 fundamental valuation is warranted -- and just imagine what will happen when people realize the genomics connection.... * Not a current holder of any securities

To: gbucks who wrote (50)	2/28/2000 4:06:00 PM
From: Jim Goodman	Read Replies (1) \| Respond to of 62

gee, but it is already way up from where I gave it out in my NL near last year's low....and look at its saucer base, wow.... often such issues opined as 'dogs' near lows, end up being loved by "the 95 %", after big rises....could this be one ? my best wishes to you, and was wondering how has your long-term-back research/track record has been, with such depressed 'dogs' like LH around $ 1., that you have predicted ? my L.T. actual historical research shows that many of these do very well off such "PSYCLE sm" patterns....do be well, regardless, guy, and I will help you if desired, enjoy,